openPR Logo
Press release

Sexually Transmitted Diseases (STDs) Drug Market is expected to reach US$ 83.04 Bn by 2025

11-17-2017 07:40 AM CET | Health & Medicine

Press release from: Transparency Market Research

Sexually Transmitted Diseases (STDs) Drug Market is expected

According to the report, global sexually transmitted diseases (STDs) drug market was valued at US$ 32,826.3 Mn in 2016 and is projected to expand at a CAGR of 11.2% from 2017 to 2025 to reach US$ 83,041.3 Mn by 2025. This report offers a thorough understanding of sexually transmitted diseases (STDs) drug market across the globe its key trends, drivers, restraints, and opportunities.

Read Report - https://www.transparencymarketresearch.com/sexually-transmitted-disease-drugs-market.html

Chlamydia is a common sexually transmitted disease. It is caused by bacteria called Chlamydia trachomatis. It can infect both men and women. Chlamydia infection spreads mainly during sex. The infection is carried in semen and vaginal fluids. Chlamydia can infect penis, vagina, cervix, anus, urethra, eyes, and throat. Gonorrhea is caused due to bacterial infection (bacterium Neisseria gonorrhoeae) that can be passed from one person to another during sex. The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss of ability to fight against the organism that causes disease. Human papillomavirus (HPV) is viral pathogens affecting individuals of all ages. Syphilis is one of the sexually transmitted infections (STI) caused by the Treponema pallidum bacteria. It can lead to complications in the long term, if not diagnosed effectively. Others (Trichomoniasis, Chancroid, Hepatitis, Pubic lice, Scabies, Candidiasis, Amoebiasis, Giardiasis)

Inquire for a Sample Copy of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=34043

The global sexually transmitted diseases (STDs) drug market can be segmented on the basis of disease type, therapy class, distribution channel, and region. On the bases of disease type, sexually transmitted diseases (STDs) drug market can be further segmented into chlamydia, gonorrhea, syphilis, human papillomavirus infection, HIV/AIDS and others. According to therapy class sexually transmitted diseases (STDs) drug market can be segmented into antibiotics, antiviral, vaccines and others.

Antibiotic is group of medicines used in the treatment of infections caused by germs—bacteria. It is a most frequently prescribed product in modern medicine. The first antibiotic was penicillin, discovered by Scottish scientist Alexander Fleming. Today, more than 100 different antibiotics are available in the market to cure minor, and life-threatening infections. An antiviral is an agent that eliminates a virus or restrains its ability to multiply and hence, prevents it from replicating and reproducing. Antiviral drugs are used in the treatment of lethal viral infections caused by viruses like human immunodeficiency virus (HIV), hepatitis, influenza A and B viruses and herpes viruses. Vaccination has been promoted as a vital public health intervention across the globe for decades. According to the World Health Organization (WHO), vaccination has reduced the global burden of infectious disease to a great extent. According to WHO, 36.7 million people were living with HIV at the end of 2016.

Download a PDF Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34043

Geographically, the global sexually transmitted diseases (STDs) drug market is segmented into five regions: North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America dominated the market and is anticipated to gain more market share from others region by the end of 2025. The growth of North America is attributed to its well established industry, adoption of new treatment and technologies. Followed by the North America, Europe is the second leading share holder of global sexually transmitted diseases (STDs) drug market. Developing economies such as China and Japan are projected to contribute to growth of the market in APAC between 2017 and 2025, due to better health care infrastructure, economic growth, increase in the number of insurance payers, growth of the private health care sector, and increasing education awareness.The economic growth allows the substantial growth of the middle income group which has enabled the group to access private health care services, and it helps in increasing government spending on the health care sector which provides greater access to health care products and services.

Key players operating in the global sexually transmitted diseases drug market are Pfizer INC, Hoffmann La Roche, Bayer Healthcare, Eli Lilly, Johnson & Johnson, Bristol-Myers Squibb Co. AbbVie, Inc., Gilead Sciences, GlaxoSmithKline Plc, and Merck & Co., Inc.

Purchase this Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=34043

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sexually Transmitted Diseases (STDs) Drug Market is expected to reach US$ 83.04 Bn by 2025 here

News-ID: 821069 • Views:

More Releases from Transparency Market Research

Solid Tires Market Expected to Witness Impressive Growth at a 8.1% CAGR by 2031
Solid Tires Market Expected to Witness Impressive Growth at a 8.1% CAGR by 2031
The latest research study released by Transparency Market Research on "Solid Tires Market Forecast to 2023-2031 ″ research provides accurate economic, global, and country-level predictions and analyses. Solid Tires market is estimated to attain a valuation of US$ 760.0 Mn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 8.1% during
Automotive Cyber security Market Sales Estimated to Hit USD 10.5 Billion by 2031| Says Transparency Market Research
Automotive Cyber security Market Sales Estimated to Hit USD 10.5 Billion by 2031 …
The latest research study released by Transparency Market Research on "𝐀𝐮𝐭𝐨𝐦𝐨𝐭𝐢𝐯𝐞 𝐂𝐲𝐛𝐞𝐫 𝐬𝐞𝐜𝐮𝐫𝐢𝐭𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟐𝟑-𝟐𝟎𝟑𝟏 ″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Automotive Cyber security industry, as
Ready-mix Concrete Market to Witness Exponential Growth with a CAGR of 6.1% from 2022 to 2031: TMR Study
Ready-mix Concrete Market to Witness Exponential Growth with a CAGR of 6.1% from …
The latest research study released by Transparency Market Research on "𝐑𝐞𝐚𝐝𝐲-𝐦𝐢𝐱 𝐂𝐨𝐧𝐜𝐫𝐞𝐭𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟐𝟑-𝟐𝟎𝟑𝟏 ″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Ready-mix Concrete industry, as well as
Mining Automation Market to Surge at 6.4% CAGR, Hitting US$ 7.3 Bn by 2031, According to TMR Study
Mining Automation Market to Surge at 6.4% CAGR, Hitting US$ 7.3 Bn by 2031, Acco …
The latest research study released by Transparency Market Research on "𝐌𝐢𝐧𝐢𝐧𝐠 𝐀𝐮𝐭𝐨𝐦𝐚𝐭𝐢𝐨𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟐𝟑-𝟐𝟎𝟑𝟏 ″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Mining Automation industry, as well as

All 5 Releases


More Releases for STDs

STDs Diagnosis Market : Industry Growth, Size, Manufacturers, Sales and Demand
ReportsnReports recently announces a latest research report titled “Global STDs Diagnosis Market 2018” which highlights the STDs Diagnosis Market size, comprehensive STDs Diagnosis Industry dynamics and high-tech updates of global STDs Diagnosis Market with respect to STDs Diagnosis Industry opportunities, threats, challenges, constraints, cost structure and current trends in the STDs Diagnosis Industry. This independent 116 Page report based on analysis over 6 Major Key Players guarantees you will remain
Sexually Transmitted Diseases (STDs) Treatment Market Opportunity Analysis, 2018 …
Sexually transmitted disease also known as venereal diseases is a clinical syndrome of infection, acquired and transmitted through sexual activity via body fluids such as semen, vaginal fluid or blood. Causative agent of STD are bacteria, parasites, yeast, and viruses. Symptoms of STDs includes skin rashes, warts, abdominal pain or genital ulcers. STDs are detected by physical examination or assays such as ELISA (Enzyme Linked Immunosorbent Assay), rapid plasma reagin
6th International Conference on HIV/AIDS, STDs and STIs
6th International Conference on HIV/AIDS, STDs and STIs is exclusively designed for immunologists & virologist, physicians, nurses/nurse practitioners, pharmacists, psychologists, behavioral researchers, Healthcare professionals, social scientists, epidemiologists, social workers, AIDS service organization (ASO) staff, students, Researchers, Academicians, Practitioners, Early Career Scholars, students along with Industries and others engaged in endeavors related to STD AIDS research and business. As HIV/AIDS is an alarming concern throughout the world, STD AIDS 2018 will mainly
Global Diagnostic Testing of STDs Market to Reach US$108.5 bn by 2019, Propelled …
Transparency Market Research has published a new report on the global diagnostic testing of STDs market. As per the report, the global diagnostic testing of STDs market is expected to expand at an 8.10% CAGR during the period from 2013 to 2019. The report, titled ‘Diagnostic Testing of STDs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019’, states that the global diagnostic testing of
Diagnostic Testing of STDs Market Research Report Forecast to 2019
As per the report, the global diagnostic testing of STDs market is expected to expand at an 8.10% CAGR during the period from 2013 to 2019. The report, states that the global diagnostic testing of STDs market is expected to progress from US$65.9 bn in 2012 to US$108.5 bn by 2019. Sexually transmitted diseases (STDs), as the name itself suggests, are diseases that spread through sexual contact. STDs are primarily
Global Diagnostic Testing of STDs Market to Reach US$108.5 bn by 2019, Propelled …
Transparency Market Research has published a new report on the global diagnostic testing of STDs market. As per the report, the global diagnostic testing of STDs market is expected to expand at an 8.10% CAGR during the period from 2013 to 2019. The report, titled ‘Diagnostic Testing of STDs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019’, states that the global diagnostic testing of